We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$9.62B
AUM Growth
+$9.12B
Cap. Flow
+$10.4B
Cap. Flow %
107.78%
Top 10 Hldgs %
35.81%
Holding
968
New
940
Increased
2
Reduced
1
Closed

Top Sells

Rank Stock Value
1
TGNA
TEGNA Inc
TGNA
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 27.77%
2 Financials 20.93%
3 Industrials 11.05%
4 Healthcare 9.88%
5 Communication Services 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTOR
26
DELISTED
MERITOR, Inc.
MTOR
$67.5M 0.7%
+1,857,505
New +$66.8M
VMW
27
DELISTED
VMware, Inc
VMW
$62.5M 0.65%
+548,743
New +$62.3M
TPTX
28
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$58.3M 0.61%
+775,000
New +$34.4M
DRE
29
DELISTED
Duke Realty Corp.
DRE
$46.1M 0.48%
+838,654
New +$45.9M
POLY
30
DELISTED
Plantronics, Inc.
POLY
$42.2M 0.44%
+1,062,886
New +$42.2M
OXY.WS icon
31
Occidental Petroleum Corp Warrants
OXY.WS
$32.2B
$41.3M 0.43%
+1,108,948
New +$44M
MANT
32
DELISTED
Mantech International Corp
MANT
$38.9M 0.4%
+407,507
New +$36.4M
FPAC
33
DELISTED
Far Peak Acquisition Corporation
FPAC
$38.3M 0.4%
+3,900,128
New +$38.4M
CPAA
34
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
$31.5M 0.33%
+3,264,653
New +$31.7M
CVET
35
DELISTED
Covetrus, Inc. Common Stock
CVET
$31.1M 0.32%
+1,496,644
New +$26.6M
HRTX icon
36
Heron Therapeutics
HRTX
$94.5M
$28.3M 0.29%
+10,145,000
New +$40.7M
SCRM
37
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$27.1M 0.28%
+2,831,116
New +$27.4M
PSTH
38
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$25.2M 0.26%
+1,263,939
New +$25.1M
GHIX
39
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$24.8M 0.26%
+2,573,742
New +$25M
SPY icon
40
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$24.6M 0.26%
+2,950,000
New +$1.21B
AAL icon
41
PUT
American Airlines Group
AAL
$10.6B
$23.9M 0.25%
+16,119,200
New +$268M
NPAB
42
DELISTED
New Providence Acquisition Corp. II Class A Common Stock
NPAB
$22.2M 0.23%
+2,227,500
New +$22.1M
AVAN
43
DELISTED
Avanti Acquisition Corp.
AVAN
$21.6M 0.22%
+2,175,398
New +$21.5M
ASZ
44
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$20.4M 0.21%
+2,093,028
New +$20.5M
MAT icon
45
Mattel
MAT
$4.21B
$20.1M 0.21%
+898,836
New +$21.2M
GAQ
46
DELISTED
Generation Asia I Acquisition Limited Class A Ordinary Shares
GAQ
$19.4M 0.2%
+1,980,000
New +$19.4M
HPLT
47
DELISTED
Home Plate Acquisition Corporation Class A Common Stock
HPLT
$19.4M 0.2%
+1,980,000
New +$19.3M
ARE icon
48
Alexandria Real Estate Equities
ARE
$8.34B
$18.4M 0.19%
+127,065
New +$21.6M
TRAQ
49
DELISTED
Trine II Acquisition Corp.
TRAQ
$18.3M 0.19%
+1,837,581
New +$18.3M
RYAAY icon
50
Ryanair
RYAAY
$31.4B
$18.1M 0.19%
+671,138
New +$22.5M

Similar funds

UBS O'Connor's Q2 2022 Portfolio in Review

As of Q2 2022, UBS O'Connor held 968 positions worth $9.62B, up 1,838% from $496M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

UBS O'Connor deployed $10.4B of net new capital in Q2 2022, opening 940 new positions and adding to 2 existing holdings. Its largest new stake was Rogers Corp: 1,780,443 shares worth $467M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 85% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was TEGNA Inc, an estimated $1.1M trimmed.

  • UBS O'Connor's largest Q2 2022 buy was Rogers Corp: 1,780,443 shares worth $467M.
  • UBS O'Connor added most to Activision Blizzard in Q2 2022, an estimated $107M increase.
  • UBS O'Connor's biggest Q2 2022 reduction was TEGNA Inc, cutting an estimated $1.1M.
  • UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
  • UBS O'Connor opened 940 new positions and closed 0 in Q2 2022.
  • UBS O'Connor's portfolio value rose 1,838% quarter-over-quarter to $9.62B.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.